Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents

Heart

Volumn 97, Issue 18, 2011, Pages 1501-1506

  Her, Sung Ho ^a   Yoo, Ki Dong ^a   Park, Chul Soo ^a   Kim, Dong Bin ^a   Lee, Jong Min ^a   Kim, Pum Joon ^a   Kim, Hee Yeol ^a   Chang, Kiyuk ^a   Jeon, Doo Soo ^a   Chung, Wook Sung ^a   Seung, Ki Bae ^a   Kim, Jae Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; ZOTAROLIMUS;

AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HEART INJURY; HEART MUSCLE REVASCULARIZATION; HETEROGENEOUS DRUG ELUTING STENT; HOMOGENEOUS DRUG ELUTING STENT; HUMAN; KOREA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SAFETY;

AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DATABASES, FACTUAL; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; TREATMENT OUTCOME;

EID: 80052165059     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.226308     Document Type: Article

References (26)

1. Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-70.
2. Sawhney N, Moses JW, Leon MB, et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 2004;110:374-9.
3. Degertekin M, Arampatzis CA, Lemos PA, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 2004;93:826-9.
4. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
5. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. (Pubitemid 38067635)
6. Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-3.
7. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
8. Goldberg SL, Loussararian A, De Gregorio J, et al. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 2001;37:1019-25.
9. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-8.
10. Otake H, Honda Y, Yamasaki M, et al. Vascular response to overlapping everolimus-eluting stents. Comparison with paclitaxel-eluting stents. Circ J 2010;74:1023-5.
11. Lim SY, Jeong MH, Hong SJ, et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ J 2008;72:463-8.
12. Burzotta F, Siviglia M, Altamura L, et al. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. Am J Cardiol 2007;99:364-8.
13. Kang WC, Oh KJ, Han SH, et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol 2007;123:12-17. (Pubitemid 350116973)
14. Raber L, Juni P, Loffel L, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 2010;55:1178-88.
15. Park DW, Kim YH, Yun SC, et al. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial. J Am Coll Cardiol 2010;56:1187-95.
16. Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009;119:987-95.
17. Kitahara H, Kobayashi Y, Takebayashi H, et al. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals. Circ J 2009;73:867-71.
18. Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006;295:895-904.
19. Cosgrave J, Melzi G, Corbett S, et al. Comparable clinical outcomes with paclitaxel-and sirolimus-eluting stents in unrestricted contemporary practice. J Am Coll Cardiol 2007;49:2320-8.
20. Simonton CA, Brodie B, Cheek B, et al. Comparative clinical outcomes of paclitaxel-and sirolimus-eluting stents: results from a large prospective multicenter registry - STENT Group. J Am Coll Cardiol 2007;50:1214-22.
21. Byrne RA, Eberle S, Kastrati A, et al. Distribution of angiographic measures of restenosis after drug-eluting stent implantation. Heart 2009;95:1572-8.
22. Kang WC, Ahn TH, Moon CI, et al. Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents. Heart 2009;95:970-5.
23. Colombo A, Chieffo A. Drug-eluting stent update 2007: part III: technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007;116:1424-32.
24. Kim YH, Park SW, Lee SW, et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 2006;114:2148-53.
25. Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006;27:260-6.
26. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart 2010;96:1574-8.